Area of research
Oncology · Rheumatology
Research interest
Research focused on Ovarian cancer and Master regulator, with related work in CXCL9, Chemokine, Antibody-dependent cell-mediated cytotoxicity. Notable publications include 'PI3K: A master regulator of brain metastasis‐promoting macrophages/microglia', 'CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer', and 'The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo'.
PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>
PI3K: A master regulator of brain metastasis‐promoting macrophages/microglia
Distante Filialisierung in der Mamma durch ein seröses Ovarialkarzinom